Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor. (Q50216428)
Jump to navigation
Jump to search
scientific article published on 13 December 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor. |
scientific article published on 13 December 2016 |
Statements
1 reference
Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor. (English)
1 reference
1 reference
Xingping Duan
1 reference
Qiang Meng
1 reference
Changyuan Wang
1 reference
Zhihao Liu
1 reference
Qi Liu
1 reference
Huijun Sun
1 reference
Pengyuan Sun
1 reference
Xiaobo Yang
1 reference
Jinyong Peng
1 reference
Kexin Liu
1 reference
13 December 2016
1 reference
1 reference
25
1 reference
83-92
1 reference
Identifiers
1 reference
1 reference